Both in Biotechnology
Kymera Therapeutics vs Bio-Techne
Over the past year KYMR returned +116.4% and TECH returned +18.6%; their daily moves had a correlation of 0.11.
KYMR +116.4% TECH +18.6%Growth of $1, one year, split-adjusted
| Metric | KYMR | TECH |
|---|---|---|
| Price | $129.23 | $72.68 |
| Market cap | $11.03B | $11.41B |
| Today | +1.35% | +0.01% |
| 1 month | +17.6% | +0.1% |
| 6 months | +56.2% | +28.2% |
| Year to date | +66.1% | +23.6% |
| 1 year | +109.0% | +16.2% |
| Revenue growth (YoY) | −100.0% | +1.3% |
| Gross margin | — | 65.8% |
| Net margin | — | 17.0% |
| P/E (TTM) | — | 62.8× |
| Price / sales | 107.9× | 9.4× |
| Net cash | $969.2M | $64.7M |
| Dividend yield | — | 0.44% |
| Volatility (60d) | 38.9% | 2.2% |
| Short % of float | 13.7% | 4.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).